Last reviewed · How we verify
Lisinopril Tablets
At a glance
| Generic name | Lisinopril Tablets |
|---|---|
| Sponsor | University of Rochester |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD (PHASE4)
- A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate Cancer (EARLY_PHASE1)
- A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of Hyperkalaemia (PHASE3)
- Centrally Acting ACE Inhibition in SLE (PHASE2)
- Optimal Management of HIV Infected Adults at Risk for Kidney Complications in Nigeria (PHASE2)
- Effect of Smartphone Application (MED-AD) on Medication Adherence Among Patients With Cardiovascular Disease in Oman (NA)
- Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study
- Prophylactic Lisinopril to Prevent Anthracycline Cardiomyopathy. (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lisinopril Tablets CI brief — competitive landscape report
- Lisinopril Tablets updates RSS · CI watch RSS
- University of Rochester portfolio CI